This work is licensed under the Creative Commons Attribution 4.0 International License.
Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, et al. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendation for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Rheum. 2016; 68:282–98.WardMMDeodharAAklEALuiAErmannJGenslerLSAmerican College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendation for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial SpondyloarthritisArthritis Rheum2016682829810.1002/art.39298512384026401991Search in Google Scholar
Maksymowych WP. Disease modification in ankylosing spondylitis. Nat Rev Rheumatol. 2010; 6:75–81.MaksymowychWPDisease modification in ankylosing spondylitisNat Rev Rheumatol20106758110.1038/nrrheum.2009.25820125174Search in Google Scholar
Lin H, Lee E, Hestir K, Leo C, Huang M, Bosch E, et al. Discovery of a cytokine and its receptor by function screening of extracellular proteome. Science. 2008; 320:807–11.LinHLeeEHestirKLeoCHuangMBoschEDiscovery of a cytokine and its receptor by function screening of extracellular proteomeScience20083208071110.1126/science.115437018467591Search in Google Scholar
Chihara T, Suzu S, Hassan R, Chutiwitoonchai N, Hiyoshi M, Motoyoshi K, et al. IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation. Cell Death Differ. 2010; 17:1917–27.ChiharaTSuzuSHassanRChutiwitoonchaiNHiyoshiMMotoyoshiKIL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activationCell Death Differ20101719172710.1038/cdd.2010.6020489731Search in Google Scholar
Wei S, Nandi S, Chitu V, Yeung Y-G, Yu W, Huang M, et al. Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor mediated regulation of myeloid cells. J Leukoc Biol. 2010; 88:495–505.WeiSNandiSChituVYeungY-GYuWHuangMFunctional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor mediated regulation of myeloid cellsJ Leukoc Biol20108849550510.1189/jlb.1209822292460520504948Search in Google Scholar
Chemel M, Le Goff B, Brion R, Cozic C, Berreur M, Amiaud J, et al. Interleukin 34 expression is associated with synovitis in rheumatoid arthritis patients. Ann Rheum Dis. 2012; 77:150–4.ChemelMLe GoffBBrionRCozicCBerreurMAmiaudJInterleukin 34 expression is associated with synovitis in rheumatoid arthritis patientsAnn Rheum Dis201277150410.1136/annrheumdis-2011-200096341361722039170Search in Google Scholar
Tian Y, Shen H, Xia L, Lu J. Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production. J Interferon Cytokine Res. 2013; 33:398–401.TianYShenHXiaLLuJElevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 productionJ Interferon Cytokine Res20133339840110.1089/jir.2012.0122370862423421370Search in Google Scholar
Moon S-J, Hong Y-S, Ju JH, Kwok S-K, Park S-H, Min J-K. Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis. J Rheumatol. 2013; 40:1842–9.MoonS-JHongY-SJuJHKwokS-KParkS-HMinJ-KIncreased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritisJ Rheumatol2013401842910.3899/jrheum.13035623996288Search in Google Scholar
Zhang F, Ding R, Li P, Ma C, Song D, Wang X, et al. Interleukin-34 in rheumatoid arthritis: potential role in clinical therapy. Int J Clin Exp Med. 2015; 8:7809–15.ZhangFDingRLiPMaCSongDWangXInterleukin-34 in rheumatoid arthritis: potential role in clinical therapyInt J Clin Exp Med20158780915Search in Google Scholar
Wang S-L, Zhang R, Hu K-Z, Li M-Q, Li Z-C. Interleukin-34 synovial fluid was associated with knee osteoarthritis severity: a cross-sectional study in knee osteoarthritis patients in different radiographic stages. Dis Markers 2018; 2018:2095480. doi: 10.1155/2018/2095480WangS-LZhangRHuK-ZLiM-QLiZ-CInterleukin-34 synovial fluid was associated with knee osteoarthritis severity: a cross-sectional study in knee osteoarthritis patients in different radiographic stagesDis Markers201820182095480.10.1155/2018/2095480610955630159102Open DOISearch in Google Scholar
Clavel G, Thiolat A, Boissier MC. Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38. Joint Bone Spine. 2013; 80:449–453.ClavelGThiolatABoissierMCInterleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38Joint Bone Spine20138044945310.1016/j.jbspin.2013.04.01423849463Search in Google Scholar
Mou Y-K, Zhang P-P, Li Q-X, Lin Z-M, Liao Z-T, Wei Q-J, Gu J-R. Changes of serum levels of MMP-3, sRANKL, and OPG in juvenile-onset ankylosing spondylitis patients carrying different HLA-B27 subtypes. Clin Rheumatol. 2015; 34:1085–9.MouY-KZhangP-PLiQ-XLinZ-MLiaoZ-TWeiQ-JGuJ-RChanges of serum levels of MMP-3, sRANKL, and OPG in juvenile-onset ankylosing spondylitis patients carrying different HLA-B27 subtypesClin Rheumatol2015341085910.1007/s10067-015-2940-z25912212Search in Google Scholar
Chen C-H, Chen H-A, Liao H-T, Liu C-H, Tsai C-Y, Chou C-T. Soluble receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation. Clin Rheumatol. 2010; 29:1155–61.ChenC-HChenH-ALiaoH-TLiuC-HTsaiC-YChouC-TSoluble receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammationClin Rheumatol20102911556110.1007/s10067-010-1543-y20690034Search in Google Scholar
Feydy A, Lavie-Brion MC, Gossec L, Lavie F, Guerini H, Nguyen C, et al. Comparative study of MRI and power Doppler ultrasonography of the heel in patients with spondyloarthritis with and without heel pain and in controls. Ann Rheum Dis. 2012; 71:498–503.FeydyALavie-BrionMCGossecLLavieFGueriniHNguyenCComparative study of MRI and power Doppler ultrasonography of the heel in patients with spondyloarthritis with and without heel pain and in controlsAnn Rheum Dis20127149850310.1136/annrheumdis-2011-20033621949008Search in Google Scholar
Kamel M, Eid H, Mansour R. Ultrasound detection of heel enthesitis: a comparison with magnetic resonance imaging. J Rheumatol. 2003; 30:774–8.KamelMEidHMansourRUltrasound detection of heel enthesitis: a comparison with magnetic resonance imagingJ Rheumatol2003307748Search in Google Scholar
Li N, Jiang L, Cai Y, Liu JY, Zhao T, Kong N, et al. The correlation between interleukin-34 and bone erosion under ultrasound in rheumatoid arthritis. Mod Rheumatol. 2019; 30:269–75.LiNJiangLCaiYLiuJYZhaoTKongNThe correlation between interleukin-34 and bone erosion under ultrasound in rheumatoid arthritisMod Rheumatol2019302697510.1080/14397595.2019.159357630880555Search in Google Scholar
Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement. Ann Intern Med. 2015; 162:55–63.CollinsGSReitsmaJBAltmanDGMoonsKGTransparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statementAnn Intern Med2015162556310.1161/CIRCULATIONAHA.114.014508429722025561516Search in Google Scholar
Schmidt SAJ, Lo S, Hollestein LM. Research techniques made simple: sample size estimation and power calculation. J Invest Dermatol. 2018; 138:1678–82.SchmidtSAJLoSHollesteinLMResearch techniques made simple: sample size estimation and power calculationJ Invest Dermatol201813816788210.1016/j.jid.2018.06.16530032783Search in Google Scholar
van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984; 27:361–8.van der LindenSValkenburgHACatsAEvaluation of diagnostic criteria for ankylosing spondylitisA proposal for modification of the New York criteria. Arthritis Rheum1984273618Search in Google Scholar
Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986; 29:1039–49.AltmanRAschEBlochDBoleGBorensteinDBrandtKDevelopment of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism AssociationArthritis Rheum19862910394910.1002/art.17802908163741515Search in Google Scholar
Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991; 34:505–14.AltmanRAlarcónGAppelrouthDBlochDBorensteinDBrandtKThe American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hipArthritis Rheum1991345051410.1002/art.17803405022025304Search in Google Scholar
Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, et al. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann Rheum Dis. 2009; 68:8–17.ZhangWDohertyMLeebBFAlekseevaLArdenNKBijlsmaJWEULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISITAnn Rheum Dis20096881710.1136/ard.2007.08477218250111Search in Google Scholar
Zhang W, Doherty M, Peat G, Bierma-Zeinstra MA, Arden NK, Bresnihan B, et al. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis. 2010; 69:483–9.ZhangWDohertyMPeatGBierma-ZeinstraMAArdenNKBresnihanBEULAR evidence-based recommendations for the diagnosis of knee osteoarthritisAnn Rheum Dis201069483910.1136/ard.2009.11310019762361Search in Google Scholar
中华医学会骨科学分会 [Chinese Medical Association Orthopaedic Branch]. 骨关节炎诊治指南(2007年版) [Guideline for diagnosis and treatment of osteoarthritis (2007 edition)]. 中华 骨科杂志 [Chin J Orthop]. 2007; 27:793–6. [in Chinese]中华医学会骨科学分会 [Chinese Medical Association Orthopaedic Branch]骨关节炎诊治指南(2007年版) [Guideline for diagnosis and treatment of osteoarthritis (2007 edition)]中华 骨科杂志 [Chin J Orthop]2007277936[in Chinese]Search in Google Scholar
Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum. 1990; 33:1601–10.AltmanRAlarcónGAppelrouthDBlochDBorensteinDBrandtKThe American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the handArthritis Rheum19903316011010.1002/art.17803311012242058Search in Google Scholar
Balint PV, Kane D, Wilson H, Mclnnes IB, Sturrock RD. Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis. 2002; 61:905–10.BalintPVKaneDWilsonHMclnnesIBSturrockRDUltrasonography of entheseal insertions in the lower limb in spondyloarthropathyAnn Rheum Dis2002619051010.1136/ard.61.10.905175391312228161Search in Google Scholar
Zhao W, Huang F. 细胞核因子κB 受体活化因子配基在强直性脊 柱炎的表达及意义 [Expression and significance of nuclear factor κB receptor activator ligand in ankylosing spondylitis]. The role of RANKL in the pathogenesis of peripheral joint bone destruction in ankylosing spondylitis. Medical J Chin PLA. 2004; 29:482–5. [English title and abstract, article in Chinese]ZhaoWHuangF细胞核因子κB 受体活化因子配基在强直性脊 柱炎的表达及意义 [Expression and significance of nuclear factor κB receptor activator ligand in ankylosing spondylitis]. The role of RANKL in the pathogenesis of peripheral joint bone destruction in ankylosing spondylitisMedical J Chin PLA2004294825[English title and abstract, article in Chinese]Search in Google Scholar
Mori H, Kitazawa R, Mizuki S, Nose M, Maeda S, Kitazawa S. RANKL ligand, RANK, and OPG expression in type II collagen-induced arthritis mouse. Histochem Cell Biol. 2002; 117:283–92.MoriHKitazawaRMizukiSNoseMMaedaSKitazawaSRANKL ligand, RANK, and OPG expression in type II collagen-induced arthritis mouseHistochem Cell Biol20021172839210.1007/s00418-001-0376-911914926Search in Google Scholar
Chen Z, Buki K, Vääräniemi J, Gu G, Väänänen HK. The critical role of IL-34 in osteoclastogenesis. PLoS One. 2011; 6:e18689. doi: 10.1371/journal.pone.0018689ChenZBukiKVääräniemiJGuGVäänänenHKThe critical role of IL-34 in osteoclastogenesisPLoS One20116e1868910.1371/journal.pone.0018689307298821494622Open DOISearch in Google Scholar
Baud’huin M, Renault R, Charrier C, Riet A, Moreau A, Brion R, et al. Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. J Pathol. 2010; 221:77–86.Baud’huinMRenaultRCharrierCRietAMoreauABrionRInterleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesisJ Pathol2010221778610.1002/path.268420191615Search in Google Scholar